CompaniesAmerican Life Science Pharmaceuticals

American Life Science Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

3

As Collaborator

1

Total Enrollment

250

By Phase

PHASE2: 2PHASE1/PHASE2: 2

By Status

RECRUITING: 2ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT00679289
NCT06359847
Hover over trial bars to see details

Recent Trials

NCT06359847Lead Sponsor
Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
PHASE2Recruiting
60 participants
Started: Nov 15, 2023 · Completed: Dec 31, 2027
NCT06359860Lead Sponsor
A Study of ST-1898 for Unresectable or Metastatic Melanoma
PHASE1/PHASE2Recruiting
64 participants
Started: Nov 7, 2023 · Completed: Dec 31, 2026
NCT06127238Lead Sponsor
Study of ST-1898 in Advanced Renal Cell Carcinoma
PHASE1/PHASE2Active, not recruiting
90 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2025
NCT00679289Collaborator
Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma
PHASE2Completed
36 participants
Started: Mar 28, 2008 · Completed: Feb 3, 2014
Funding History (1)
D
May 23, 2016
Filing